Loading...
SUS logo

Surgical Science Sweden AB (publ)OM:SUS Stock Report

Market Cap SEK 4.7b
Share Price
SEK 90.75
My Fair Value
SEK 163
44.3% undervalued intrinsic discount
1Y-24.3%
7D-2.3%
Portfolio Value
View

Surgical Science Sweden AB (publ)

OM:SUS Stock Report

Market Cap: SEK 4.7b

Surgical Science Sweden (SUS) Stock Overview

Develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. More details

SUS fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance2/6
Financial Health5/6
Dividends0/6

SUS Community Fair Values

Create Narrative

See what 16 others think this stock is worth. Follow their fair value or set your own to get alerts.

Surgical Science Sweden AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Surgical Science Sweden
Historical stock prices
Current Share PriceSEK 90.75
52 Week HighSEK 192.40
52 Week LowSEK 91.90
Beta0.52
1 Month Change-9.16%
3 Month Change-38.43%
1 Year Change-24.31%
3 Year Change-40.06%
5 Year Change26.04%
Change since IPO689.13%

Recent News & Updates

Recent updates

Surgical Science Sweden's (STO:SUS) Conservative Accounting Might Explain Soft Earnings

Aug 31
Surgical Science Sweden's (STO:SUS) Conservative Accounting Might Explain Soft Earnings

Earnings Miss: Surgical Science Sweden AB (publ) Missed EPS And Analysts Are Revising Their Forecasts

Aug 24
Earnings Miss: Surgical Science Sweden AB (publ) Missed EPS And Analysts Are Revising Their Forecasts

What You Can Learn From Surgical Science Sweden AB (publ)'s (STO:SUS) P/E After Its 32% Share Price Crash

Aug 20
What You Can Learn From Surgical Science Sweden AB (publ)'s (STO:SUS) P/E After Its 32% Share Price Crash

The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS) Even After Diving 27%

Mar 14
The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS) Even After Diving 27%

Surgical Science Sweden's (STO:SUS) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Mar 01
Surgical Science Sweden's (STO:SUS) Sluggish Earnings Might Be Just The Beginning Of Its Problems
User avatar

Regulatory Approvals For New Robotics Entrants Will Drive Demand For Simulation Products

Strength in the Educational Products segment and rising demand for simulators indicate potential revenue growth and diversification opportunities.

The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS)

Nov 12
The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS)

Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next

Aug 25
Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next

Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Apr 21
Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors

Apr 16
Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors

Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump

Mar 17
Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump

Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 24
Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts

Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?

Nov 29
Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?

Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?

Oct 07
Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?

Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?

Aug 17
Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?

With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case

Jun 20
With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case

A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

May 17
A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate

Dec 27
Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate

Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?

Dec 06
Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?

Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Sep 08
Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?

We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease

Aug 23
We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease

Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless

May 26
Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless

Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching

Apr 29
Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching

An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued

Feb 20
An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Jan 11
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Dec 15
Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Sep 16
Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Shareholder Returns

SUSSE Medical EquipmentSE Market
7D-2.3%1.8%1.3%
1Y-24.3%-17.9%0.6%

Return vs Industry: SUS underperformed the Swedish Medical Equipment industry which returned -17.9% over the past year.

Return vs Market: SUS underperformed the Swedish Market which returned 0.6% over the past year.

Price Volatility

Is SUS's price volatile compared to industry and market?
SUS volatility
SUS Average Weekly Movement8.7%
Medical Equipment Industry Average Movement7.5%
Market Average Movement5.8%
10% most volatile stocks in SE Market12.1%
10% least volatile stocks in SE Market3.0%

Stable Share Price: SUS's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: SUS's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
1997327Tom Englundwww.surgicalscience.com

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room.

Surgical Science Sweden AB (publ) Fundamentals Summary

How do Surgical Science Sweden's earnings and revenue compare to its market cap?
SUS fundamental statistics
Market capSEK 4.71b
Earnings (TTM)SEK 92.45m
Revenue (TTM)SEK 943.23m
50.1x
P/E Ratio
4.9x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SUS income statement (TTM)
RevenueSEK 943.23m
Cost of RevenueSEK 303.15m
Gross ProfitSEK 640.08m
Other ExpensesSEK 547.64m
EarningsSEK 92.45m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Nov 13, 2025

Earnings per share (EPS)1.81
Gross Margin67.86%
Net Profit Margin9.80%
Debt/Equity Ratio0.04%

How did SUS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/11 17:52
End of Day Share Price 2025/09/11 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Surgical Science Sweden AB (publ) is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Simon JonssonBerenberg
Viktor HögbergDanske Bank
Jonatan AnderssonDNB Carnegie